Entero Healthcare Solutions Ltd
Entero Healthcare Solutions Ltd (ENTERO) last reported results for the quarter ended Jun 2026, with sales of ₹1,940 crore and net profit of ₹52 crore. The stock last traded at ₹1,714, a market capitalisation of ₹7,461 crore, on a P/E of 57.8. Over the past 52 weeks the stock has ranged between ₹944 and ₹1,920. Figures are as of 6 Oct 2026 and are not real time.
Entero Healthcare Solutions Ltd share price and key metrics
- Current price
- ₹1,714
- Market cap
- ₹7,461 cr
- Stock P/E
- 57.8
- Book value
- ₹388
- ROE
- 6.94%
- ROCE
- 10.5%
- Dividend yield
- 0.00%
- 52w high / low
- 1920/944
Metrics as of 6 Oct 2026. Not real time.
Track Entero Healthcare Solutions Ltd
Cruxal reads every Entero Healthcare Solutions Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Entero Healthcare Solutions Ltd growth and returns
- 10 Years
- %
- 5 Years
- 30%
- 3 Years
- 26%
- TTM
- 32%
- 10 Years
- %
- 5 Years
- 57%
- 3 Years
- 130%
- TTM
- 26%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- 59%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 6%
- Last Year
- 7%
Entero Healthcare Solutions Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹1,940 cr, up 38.2% from ₹1,404 cr a year earlier. Net profit was ₹52 cr, up 73.3% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,301 | 1,359 | 1,339 | 1,404 | 1,571 | 1,707 | 1,910 | 1,940 |
| Expenses | 1,258 | 1,309 | 1,290 | 1,354 | 1,509 | 1,639 | 1,824 | 1,844 |
| Operating profit | 42 | 50 | 49 | 50 | 62 | 68 | 86 | 97 |
| OPM % | 3.3% | 3.7% | 3.6% | 3.6% | 4.0% | 4.0% | 4.5% | 5% |
| Other income | 11 | 8 | 7 | 6 | 5 | -4 | 4 | 3 |
| Interest | 11 | 10 | 10 | 11 | 12 | 14 | 17 | 21 |
| Depreciation | 7 | 8 | 8 | 9 | 10 | 10 | 15 | 12 |
| Profit before tax | 35 | 39 | 37 | 36 | 45 | 40 | 58 | 67 |
| Tax % | 25% | 25% | 16% | 17% | 18% | 16% | 22% | 22% |
| Net profit | 26 | 29 | 31 | 30 | 37 | 34 | 45 | 52 |
| EPS (₹) | 5.43 | 5.85 | 5.90 | 6.39 | 7.26 | 6.35 | 6.44 | 8.77 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Entero Healthcare Solutions Ltd annual results
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,350 | 1,773 | 2,522 | 3,300 | 3,922 | 5,096 | 6,591 | 7,128 |
| Operating profit | 23 | 15 | 24 | 64 | 112 | 172 | 266 | 313 |
| OPM % | 1.7% | 0.8% | 1.0% | 1.9% | 2.9% | 3.4% | 4.0% | 4.4% |
| Net profit | 1 | -15 | -29 | -11 | 40 | 107 | 146 | 168 |
| EPS (₹) | 93.81 | -1,550.90 | -77.71 | -28.12 | 8.99 | 21.79 | 26.44 | 28.82 |
TTM is the trailing twelve months to the most recent quarter.
Entero Healthcare Solutions Ltd balance sheet
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 0.10 | 0.10 | 4 | 4 | 43 | 44 | 44 |
| Reserves | -16 | -32 | -62 | -73 | 1,595 | 1,681 | 1,645 |
| Borrowings | 603 | 720 | 974 | 1,101 | 338 | 385 | 677 |
| Other liabilities | 162 | 147 | 210 | 275 | 369 | 593 | 1,234 |
| Total liabilities | 749 | 836 | 1,125 | 1,308 | 2,345 | 2,703 | 3,600 |
| Fixed assets | 186 | 189 | 262 | 268 | 289 | 559 | 958 |
| CWIP | 2 | 2 | 1 | 0 | 0 | 0 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 58 | 130 |
| Other assets | 560 | 645 | 863 | 1,040 | 2,056 | 2,085 | 2,510 |
| Total assets | 749 | 836 | 1,125 | 1,308 | 2,345 | 2,703 | 3,600 |
As reported by the company. Total assets equal total liabilities by construction.
Entero Healthcare Solutions Ltd cash flow
| ₹ crore | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -37 | -69 | -35 | -45 | -37 | -77 | 96 |
| Cash from investing | -203 | -31 | -162 | -49 | -704 | 232 | -302 |
| Cash from financing | 217 | 89 | 211 | 73 | 863 | -74 | 124 |
| Net cash flow | -23 | -11 | 14 | -21 | 122 | 82 | -82 |
| Free cash flow | -81 | -78 | -45 | -51 | -41 | -87 | 29 |
| CFO / operating profit | -134% | -430% | -100% | -51% | -21% | -23% | 56% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Entero Healthcare Solutions Ltd operating ratios
| Per year | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | — | 1% | 1% | 5% | 7% | 9% | 10% |
| Debtor days | 63 | 50 | 54 | 57 | 57 | 59 | 67 |
| Inventory days | 57 | 54 | 49 | 41 | 43 | 52 | 52 |
| Days payable | 32 | 22 | 22 | 25 | 24 | 31 | 45 |
| Cash conversion cycle | 88 | 82 | 81 | 73 | 77 | 80 | 74 |
| Working capital days | 57 | 54 | 41 | 32 | 48 | 65 | 35 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Entero Healthcare Solutions Ltd shareholding pattern
Promoters held 52.40% at Jun 2026, broadly unchanged since Jun 2025. FIIs 4.36% and DIIs 15.48%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 52.44% | 52.44% | 52.42% | 52.42% | 52.42% | 52.42% | 52.42% | 52.40% |
| FIIs | 23.82% | 22.20% | 19.92% | 17.21% | 14.68% | 5.14% | 4.03% | 4.36% |
| DIIs | 7.73% | 8.78% | 9.63% | 10.19% | 9.64% | 16.42% | 16.62% | 15.48% |
| Public | 16.02% | 16.59% | 18.03% | 20.19% | 23.26% | 26.03% | 26.94% | 27.77% |
| No. of shareholders | 36,767 | 33,172 | 33,159 | 33,338 | 36,334 | 40,333 | 39,084 | 39,709 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Entero Healthcare Solutions Ltd corporate filings
- Intimation of Closure of Trading WindowInsider Trading / SASTlow impact
- Entero Healthcare Solutions Ltd schedules analyst and institutional investor meetingsCompany Updatelow impact
Cruxal's analysis: Entero Healthcare Solutions has issued an intimation regarding upcoming meetings with…
Read the full analysis - Prasid Uno Family Trust Divests 21.30 Lakh Shares of Entero Healthcare SolutionsInsider Trading / SASTmedium impact
Cruxal's analysis: Prasid Uno Family Trust has reduced its stake in Entero Healthcare Solutions Limited by…
Read the full analysis - Entero Healthcare Solutions Limited provides general corporate updateCompany Updatelow impact
Cruxal's analysis: Entero Healthcare Solutions Limited has issued a notification to the exchange regarding…
Read the full analysis - Prasid Uno Family Trust acquires 10.88 lakh shares of Entero Healthcare Solutions Limited via block dealInsider Trading / SASTmedium impact
Cruxal's analysis: Prasid Uno Family Trust has increased its stake in Entero Healthcare Solutions Limited by…
Read the full analysis - Entero Healthcare Solutions schedules analyst and institutional investor meetingsCompany Updatelow impact
Cruxal's analysis: Entero Healthcare Solutions has issued an intimation regarding scheduled meetings with…
Read the full analysis - Entero Healthcare Solutions Limited announces completion of tenure for Independent Director Rajesh Shashikant DalalCompany Updatelow impact
Cruxal's analysis: Entero Healthcare Solutions Limited has formally announced that Mr. Rajesh Shashikant…
Read the full analysis - Entero Healthcare Solutions Limited concludes 8th Annual General Meeting with all resolutions passedAGM/EGMlow impact
Cruxal's analysis: Entero Healthcare Solutions Limited has successfully concluded its 8th Annual General…
Read the full analysis - Entero Healthcare Solutions Q1 FY27 Earnings Call Transcript: Strong Revenue Growth and Margin ExpansionCompany Updatehigh impact
Cruxal's analysis: Entero Healthcare Solutions Limited reported a strong start to FY27 with consolidated…
Read the full analysis - Entero Healthcare Solutions Limited uploads audio recording of Q1 FY27 earnings conference callCompany Updatelow impact
Cruxal's analysis: Entero Healthcare Solutions Limited has formally notified the stock exchanges regarding…
Read the full analysis - Entero Healthcare Solutions reports Q1 FY27 financial results with revenue of 1,940 crore and net profit of 52 croreCompany Updatelow impact
Cruxal's analysis: Entero Healthcare Solutions Limited has released its unaudited financial results for the…
Read the full analysis - Entero Healthcare Solutions Reports Strong Q1 FY27 Performance with 38.2% YoY Revenue Growth and Margin ExpansionCompany Updatehigh impact
Cruxal's analysis: Entero Healthcare Solutions Limited reported a robust Q1 FY27, with consolidated revenue…
Read the full analysis - Entero Healthcare Solutions Reports Strong Q1 FY27 Consolidated Revenue Growth of 38% YoYBoard Meetinghigh impact
Cruxal's analysis: Entero Healthcare Solutions Limited reported consolidated revenue from operations of…
Read the full analysis - Entero Healthcare Solutions Limited schedules Q1 FY27 earnings conference call for August 10, 2026Company Updatelow impact
Cruxal's analysis: Entero Healthcare Solutions Limited has issued a revised intimation regarding its…
Read the full analysis - Entero Healthcare Solutions Limited schedules Q1 FY27 earnings conference call for August 10, 2026Company Updatelow impact
Cruxal's analysis: Entero Healthcare Solutions Limited has announced an earnings conference call to discuss…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.